Author

Dan Chen

Institution: Axsome Therapeutics (United States)

Observed institution: Axsome Therapeutics (United States)

OpenAlex ID: A5135691702

ENCORE: Topline Results of a Phase Three Open-label Extension and Randomized-withdrawal Trial of AXS-12 in Narcolepsy (P6-14.006)

2026 · Richard Bogan, Michael Thorpy, et al. · Neurology

Impact of AXS-12 on Symptom Severity and Functional Impairment in Narcolepsy: Results From the Phase Three SYMPHONY Trial (S3.008)

2026 · Michael Thorpy, Lois Krahn, et al. · Neurology

0731 Cognitive and Functional Outcomes from the Phase 3 Open-Label Extension and Randomized-Withdrawal ENCORE Trial of AXS-12 in Narcolepsy with Cataplexy

2026 · Bruce Corser, Michael Thorpy, et al. · SLEEP

Works count: 3

Citation count:

H-index:

I10-index: